Search the web
Welcome, Guest
[Sign Out, My Account]
 EDGAR_Online

Insider Filings - MELAS KYRIAZI THEO
Last Updated 
9-Feb-10
Enter symbol:
symbol lookup
 

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

MELAS KYRIAZI THEO: Declared Holdings
Company/RelationshipReportedShares  Ownership
Helicos BioSciences Corporation
Director
NasdaqGM:HLCS
(historical quotes, profile, other insiders) 		15-Jan-1034,614  Direct
VALEANT PHARMA INTL
Director
NYSE:VRX
(historical quotes, profile, other insiders) 		4-Jan-1044,166  Direct

Insider & restricted shareholder transactions reported over the last two years
DateSharesStockTransaction
15-Jan-10 14,954HLCS Acquisition (Non Open Market) at $0 per share.
4-Jan-10 591VRX Acquisition (Non Open Market) at $0 per share.
15-Oct-09 3,787HLCS Acquisition (Non Open Market) at $0 per share.
1-Oct-09 346VRX Acquisition (Non Open Market) at $0 per share.
1-Jul-09 363VRX Acquisition (Non Open Market) at $0 per share.
28-May-09 57VRX Acquisition (Non Open Market) at $0 per share.
14-May-09 15,000VRX Purchase at $19.50 - $19.54 per share.
(Cost of about $293,000)
12-May-09 6,678VRX Acquisition (Non Open Market) at $0 per share.
15-Apr-09 15,873HLCS Acquisition (Non Open Market) at $0 per share.
1-Apr-09 262VRX Acquisition (Non Open Market) at $0 per share.
30-Mar-09 43VRX Acquisition (Non Open Market) at $0 per share.
2-Mar-09 158VRX Acquisition (Non Open Market) at $0 per share.
2-Jan-09 204VRX Acquisition (Non Open Market) at $0 per share.
20-May-08 7,757VRX Acquisition (Non Open Market) at $0 per share.

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

Copyright © 2010 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.
Questions or Comments?